Phase IIb Study of STA-2 in Patients With Chronic Stable Angina

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 186 participants.

Also called NCT01239511

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 186 participants (enrolled count) (from the registry)
Sponsor
Sinphar Pharmaceutical Co., Ltd (from the registry)
Registry
  • NCT NCT01239511
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Taiwan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01239511. Randomized; double masking; primary purpose treatment. Start 2010-11 (registry gives no type); primary completion 2012-04 (actual). Results posted on 2014-08-27.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Phase IIb Study of STA-2 in Patients With Chronic Stable Angina
Condition
Chronic Stable Angina
Intervention (Drug)
green tea polyphenols (STA-2)
Lead sponsor
Sinphar Pharmaceutical Co., Ltd (class: other)

Record details

Record id
cardio:ct-nct01239511
Content hash
6172d18f3661a67b21cd0cf3833ce36d759c185cc4a93f52376d7acf4e685594